NCT06394713 2024-05-01
A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
Qilu Pharmaceutical Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.